Germany
Japan
United Kingdom
China
USD 428.00
In Stock
Antibodies
Download
Goat Anti-Rabbit IgG Secondary Antibody
| Applications | WB, IHC, IF/ICC, ELISA |
| Reactivities | Rabbit IgG |
| Conjugation | Unconjugated |
| Immunogen | Rabbit IgG, whole molecule |
USD 180.00
In Stock
DDK Rabbit monoclonal antibody,clone OTIR5G2, recognizes both N-terminal and C-terminal DDK tags
| Applications | ELISA, IP, WB |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
Biotinylated Anti-Human IL-17E Rabbit Polyclonal Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | E.coli derived Recombinant Human IL-17E |
Goat Anti-Mouse IgG Secondary Antibody
| Applications | WB, IHC, IF/ICC, ELISA |
| Reactivities | Mouse IgG |
| Conjugation | Unconjugated |
| Immunogen | Mouse IgG, whole molecule |
Rabbit Anti-Mouse IgG Secondary Antibody
| Applications | WB, IHC, IF/ICC, ELISA |
| Reactivities | Mouse IgG |
| Conjugation | Unconjugated |
| Immunogen | Mouse IgG, whole molecule |
Rabbit Polyclonal H3K9/14ac Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K9/14ac antibody: histone H3 acetylated at lysines 9 and 14 (H3K9/14ac), using a KLH-conjugated synthetic peptide. |
USD 428.00
In Stock
Rabbit Anti-Goat IgG Secondary Antibody
| Applications | WB, IHC, IF/ICC, ELISA |
| Reactivities | Goat IgG |
| Conjugation | Unconjugated |
| Immunogen | Goat IgG, whole molecule |
Rabbit Monoclonal Anti-Human IgG4 Antibody, Clone RM120
| Applications | ELISA: 50ng/well - 200ng/well for Capture;, 0.05ug/mL - 0.2ug/mL for Detection;, , WB: 0.5 ug/mL - 2 ug/mL;, ICC: 1 ug/mL-10ug/mL;, IHC: 1 ug/mL-10ug/mL |
| Reactivities | Human IgG4 |
| Conjugation | Unconjugated |
Rabbit Polyclonal H3K9me2 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K9me2 antibody: the region of histone H3 containing the dimethylated lysine 9 (H3K9me2), using a KLH-conjugated synthetic peptide. |
USD 428.00
In Stock
Rabbit Polyclonal H3K27me3S28p Antibody
| Applications | Dot, ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K27me3S28p antibody: histone H3 containing the trimethylated lysine 27 and the phosphorylated serine 28 (H3K27me3S28p), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3S10p Antibody
| Applications | Dot, ELISA, IF, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3S10p antibody: histone H3 containing the phosphorylated serine 10 (H3S10p), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K27me3 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K27me3 antibody: against histone H3, trimethylated at lysine 27 (H3K27me3), using a KLH-conjugated synthetic peptide. |
TGF beta 1 (TGFB1) mouse monoclonal antibody, clone TB21, Azide Free
| Applications | ELISA, FN, IHC, WB |
| Reactivities | Human, Sheep |
| Conjugation | Unconjugated |
Rabbit Polyclonal H3K36me2 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K36me2 antibody: histone H3 containing the dimethylated lysine 36 (H3K36me2), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K4me2 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K4me2 antibody: histone H3 containing the dimethylated lysine 4 (H3K4me2), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K79me2 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K79me2 antibody: the region of histone H3 containing the dimethylated lysine 79 (H3K79me2), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K18ac Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human, Mouse, Broad |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K18ac antibody: the region of histone H3 containing the acetylated lysine 18 (H3K18ac), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3R17me2(asym)K18ac Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human, Mouse, Broad |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3R17me2(asym)K18ac antibody: the region of histone H3 containing the asymmetrically dimethylated R17 and the acetylated lysine 18 (H3R17me2(asym)K18ac), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H4K5,8,12ac Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human, Mouse, Broad |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H4K5,8,12ac antibody: the region of histone H4 containing the acetylated lysines 5, 8 and 12 (H4K5,8,12ac), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H4K20me3 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H4K20me3 antibody: the region of histone H4 containing the trimethylated lysine 20 (H4K20me3), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K9me1 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K9me1 antibody: histone H3 containing the monomethylated lysine 9 (H3K9me1), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K9acS10p Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K9acS10p antibody: histone H3 containing the acetylated lysine 9 and the phosphorylated serine 10 (H3K9acS10p), using a KLH-conjugated synthetic peptide |
Rabbit Polyclonal H3K9me3S10p Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K9me3S10p antibody: histone H3 containing trimethylated lysine 9 and the phosphorylated serine 10 (H3K9me3S10p), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K4me1 Antibody
| Applications | Dot, ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K4me1 antibody: histone H3 containing the monomethylated lysine 4 (H3K4me1), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K27me1 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K27me1 antibody: histone H3 containing the monomethylated lysine 27 (H3K27me1), using a KLH-conjugated synthetic peptide. |
Rabbit Polyclonal H3K27me2 Antibody
| Applications | Dot, ELISA, IF, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for anti-H3K27me2 antibody: the histone H3, dimethylated at lysine 27 (H3K27me2), using a KLH-conjugated synthetic peptide. |
Active filters
Applications
- ELISA
Conjugates
- Unconjugated
Filter by
Target Symbol
- UCHL1 (124)
- S PROTEIN (123)
- IL6 (116)
- LCN2 (113)
- IL1RL1 (105)
- GFAP (101)
- N PROTEIN (96)
- IL17A (93)
- S100A8/A9 (87)
- D-DIMER (81)
- MPO (80)
- SAA1 (80)
- FABP3 (68)
- MYBPC3 (63)
- REG1A (62)
- NEFL (49)
- CAPSID (48)
- H3C1 (37)
- NPPB (37)
- IGG4 (36)
- AMH (32)
- POMC (29)
- S (26)
- MAPT (25)
- NPPA (23)
- EDN1 (21)
- PDCD1 (20)
- S100B (20)
- CALCA (19)
- PDYN (19)
- TNF (19)
- EGFR (18)
- IL2 (18)
- CD80 (17)
- IFNG (17)
- PENK (16)
- EGF (15)
- HIS (15)
- PTH (15)
- SARS-COV-2 SPIKE PROTEIN (15)
- V5 (15)
- CD274 (14)
- CD44 (14)
- CSF2 (14)
- FN1 (14)
- GCG (14)
- F13A1 (13)
- MUC1 (13)
- PON1 (13)
- ADCYAP1 (12)
- CCL2 (12)
- CCL3 (12)
- GAL (12)
- IAPP (12)
- INS (12)
- BRAF (11)
- FOLH1 (11)
- VEGFA (11)
- B2M (10)
- DDK (10)
- IL4 (10)
- PTHLH (10)
- VSIR (10)
- AGT (9)
- AKT1 (9)
- AVP (9)
- CCR5 (9)
- CD4 (9)
- CHGA (9)
- FSHB (9)
- GHRL (9)
- H4-16 (9)
- IL16 (9)
- MSMB (9)
- NMU (9)
- SARS-COV-2 N PROTEIN (9)
- ADM (8)
- CD5 (8)
- GHRH (8)
- GRP (8)
- IGF1 (8)
- IL10 (8)
- KLK8 (8)
- MAP2K1 (8)
- MSLN (8)
- N (8)
- SERPINB3 (8)
- SST (8)
- TAC1 (8)
- TP53 (8)
- VIP (8)
- AFP (7)
- APP (7)
- BRCA1 (7)
- CCL11 (7)
- CSF1 (7)
- CXCL10 (7)
- CXCL8 (7)
- FGF2 (7)
- GAG (7)
Reactivities
- Human (5054)
- Mouse (1533)
- Rat (1349)
- SARS-CoV-2 (271)
- Mammalian (127)
- Porcine (97)
- Murine (82)
- Monkey (74)
- Bovine (58)
- HIV (48)
- Dog (44)
- Rabbit (25)
- Canine (16)
- Chicken (11)
- Pig (11)
- Primate (11)
- C-term DDK (10)
- Virus (10)
- Feline (9)
- Guinea Pig (9)
- Vertebrates (9)
- Cow (8)
- Goat (8)
- SARS-CoV (8)
- Sheep (8)
- Broad (5)
- Chimpanzee (5)
- Escherichia coli (3)
- Hamster (3)
- Respiratory Syncytial Virus (3)
- Zebrafish (3)
- Avian (2)
- Bacteria (2)
- Cynomolgus (2)
- Dengue virus (2)
- Ferret (2)
- Horse (2)
- Insect (2)
- N-term and C-term DDK (2)
- West Nile Virus (2)
- Yeast (2)
- Yellow Fever Virus (2)
- 5-FAM (1)
- Bacillus Antracis (1)
- Biotin (1)
- C. elegans (1)
- Digoxin (1)
- FITC (1)
- Fish (1)
- Fusion proteins containing the Flag Tag (1)
- Horseradish Peroxidase (1)
- Staphylococcus aureus (1)
- Xenopus (1)
Antibody Hosts
Isotypes
- IgG (2513)
- IgG1 (1773)
- IgG2b (302)
- IgG2a (249)
- IgG, kappa (166)
- IgG1, kappa (124)
- IgG2a, kappa (35)
- IgG2b, kappa (15)
- IgG1, lambda (11)
- IgG1-Fc Fusion (8)
- IgM (8)
- IgG2c (6)
- IgG3 (5)
- IgG3, kappa (5)
- IgM, kappa (5)
- IgA-Fc Fusion (4)
- IgG-Fc Fusion (4)
- IgM-Fc Fusion (4)
- IgG2, kappa (2)
- IgG2a, lambda (2)
- IgG4 (2)
- Ig (1)
- IgA (1)
Clonalities
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (47)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (6)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho-specific (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (2095)
- Secreted Protein (1021)
- Transmembrane (628)
- ES Cell Differentiation/IPS (374)
- Transcription Factors (230)
- Protease (221)
- Protein Kinase (124)
- Stem cell - Pluripotency (97)
- Adult stem cells (52)
- Embryonic stem cells (41)
- Cancer stem cells (32)
- Induced pluripotent stem cells (27)
- Stem cell relevant signaling - JAK/STAT signaling pathway (21)
- GPCR (18)
- Stem cell relevant signaling - DSL/Notch pathway (18)
- Phosphatase (17)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (9)
- Ion Channels: Other (8)
- Nuclear Hormone Receptor (6)
- P450 (6)
- Stem cell relevant signaling - Wnt Signaling pathway (5)
- Ion Channels: Transient receptor potential (3)
- Ion Channels: Cyclic nucleotide gated (1)
- Ion Channels: Potassium (1)
- Ion Channels: Sodium (1)
Pathways
- Cytokine-cytokine receptor interaction (497)
- Pathways in cancer (324)
- Jak-STAT signaling pathway (235)
- Hematopoietic cell lineage (200)
- Toll-like receptor signaling pathway (195)
- Hypertrophic cardiomyopathy (HCM) (191)
- MAPK signaling pathway (167)
- NOD-like receptor signaling pathway (156)
- Graft-versus-host disease (150)
- Metabolic pathways (140)
- Prion diseases (139)
- Chemokine signaling pathway (133)
- Parkinson's disease (130)
- Cytosolic DNA-sensing pathway (127)
- Focal adhesion (118)
- T cell receptor signaling pathway (103)
- Regulation of actin cytoskeleton (101)
- Prostate cancer (98)
- Melanoma (88)
- PPAR signaling pathway (86)
- ErbB signaling pathway (84)
- Systemic lupus erythematosus (84)
- Dilated cardiomyopathy (83)
- Cell adhesion molecules (CAMs) (81)
- Pancreatic cancer (79)
- Amyotrophic lateral sclerosis (ALS) (75)
- Bladder cancer (75)
- Colorectal cancer (75)
- Glioma (75)
- Endometrial cancer (70)
- Natural killer cell mediated cytotoxicity (70)
- Alzheimer's disease (68)
- TGF-beta signaling pathway (66)
- Chronic myeloid leukemia (64)
- Neurotrophin signaling pathway (64)
- Non-small cell lung cancer (64)
- Apoptosis (61)
- Fc epsilon RI signaling pathway (59)
- Insulin signaling pathway (57)
- Renal cell carcinoma (54)
- GnRH signaling pathway (53)
- Acute myeloid leukemia (52)
- Endocytosis (52)
- Progesterone-mediated oocyte maturation (52)
- Gap junction (51)
- Type I diabetes mellitus (51)
- Allograft rejection (50)
- Adipocytokine signaling pathway (46)
- Autoimmune thyroid disease (44)
- Small cell lung cancer (44)
- B cell receptor signaling pathway (43)
- Neuroactive ligand-receptor interaction (42)
- Cell cycle (41)
- Vascular smooth muscle contraction (39)
- Epithelial cell signaling in Helicobacter pylori infection (38)
- Melanogenesis (38)
- Complement and coagulation cascades (37)
- p53 signaling pathway (37)
- RIG-I-like receptor signaling pathway (36)
- mTOR signaling pathway (36)
- ECM-receptor interaction (35)
- Thyroid cancer (34)
- Wnt signaling pathway (34)
- Long-term depression (33)
- Fc gamma R-mediated phagocytosis (32)
- Adherens junction (31)
- Long-term potentiation (30)
- Oocyte meiosis (30)
- Type II diabetes mellitus (27)
- VEGF signaling pathway (27)
- Huntington's disease (25)
- Tight junction (25)
- Asthma (24)
- Calcium signaling pathway (24)
- Glycolysis / Gluconeogenesis (24)
- Leukocyte transendothelial migration (24)
- Viral myocarditis (24)
- Dorso-ventral axis formation (22)
- Antigen processing and presentation (21)
- Axon guidance (21)
- Proteasome (19)
- Regulation of autophagy (19)
- Ubiquitin mediated proteolysis (19)
- Cysteine and methionine metabolism (17)
- Metabolism of xenobiotics by cytochrome P450 (16)
- Purine metabolism (16)
- Pathogenic Escherichia coli infection (15)
- Basal cell carcinoma (14)
- Notch signaling pathway (14)
- Arginine and proline metabolism (13)
- Tyrosine metabolism (12)
- Cardiac muscle contraction (10)
- Glutathione metabolism (10)
- Nitrogen metabolism (10)
- Pyrimidine metabolism (10)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (9)
- Drug metabolism - cytochrome P450 (9)
- Fatty acid metabolism (9)
- Homologous recombination (9)
- Lysosome (9)
- Maturity onset diabetes of the young (9)
- RNA degradation (9)
- Tryptophan metabolism (9)
- ABC transporters (8)
- Arachidonic acid metabolism (8)
- Hedgehog signaling pathway (8)
- Histidine metabolism (8)
- Lysine degradation (8)
- Nucleotide excision repair (8)
- Primary immunodeficiency (8)
- Pyruvate metabolism (8)
- Citrate cycle (TCA cycle) (7)
- Mismatch repair (7)
- Renin-angiotensin system (7)
- Valine (7)
- leucine and isoleucine degradation (7)
- Base excision repair (6)
- Folate biosynthesis (6)
- N-Glycan biosynthesis (6)
- Retinol metabolism (6)
- Spliceosome (6)
- Biosynthesis of unsaturated fatty acids (5)
- Butanoate metabolism (5)
- DNA replication (5)
- Nicotinate and nicotinamide metabolism (5)
- Non-homologous end-joining (5)
- One carbon pool by folate (5)
- Phenylalanine metabolism (5)
- Porphyrin and chlorophyll metabolism (5)
- Propanoate metabolism (5)
- Vibrio cholerae infection (5)
- beta-Alanine metabolism (5)
- Fructose and mannose metabolism (4)
- Glycerolipid metabolism (4)
- Linoleic acid metabolism (4)
- Oxidative phosphorylation (4)
- Pentose phosphate pathway (4)
- Starch and sucrose metabolism (4)
- Alanine (3)
- Aminoacyl-tRNA biosynthesis (3)
- Caffeine metabolism (3)
- Olfactory transduction (3)
- Riboflavin metabolism (3)
- Ribosome (3)
- SNARE interactions in vesicular transport (3)
- Taste transduction (3)
- aspartate and glutamate metabolism (3)
- Amino sugar and nucleotide sugar metabolism (2)
- Ascorbate and aldarate metabolism (2)
- Cyanoamino acid metabolism (2)
- Drug metabolism - other enzymes (2)
- Ether lipid metabolism (2)
- Glycine (2)
- Limonene and pinene degradation (2)
- Primary bile acid biosynthesis (2)
- alpha-Linolenic acid metabolism (2)
- serine and threonine metabolism (2)
- Androgen and estrogen metabolism (1)
- C21-Steroid hormone metabolism (1)
- Fatty acid biosynthesis (1)
- Fatty acid elongation in mitochondria (1)
- Galactose metabolism (1)
- Glycerophospholipid metabolism (1)
- Inositol phosphate metabolism (1)
- Lysine biosynthesis (1)
- Methane metabolism (1)
- Other glycan degradation (1)
- Pentose and glucuronate interconversions (1)
- Phenylalanine (1)
- Phosphatidylinositol signaling system (1)
- Selenoamino acid metabolism (1)
- Sphingolipid metabolism (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- Vitamin B6 metabolism (1)
- tyrosine and tryptophan biosynthesis (1)